Actions for Advances in medicine and biology. Volume 38

Email RIS file
Bookmark
Report an Issue

Advances in medicine and biology. Volume 38 / Leon V. Berhardt, editor

Published
New York : Nova Science, [2012]
Copyright Date
©2012
Physical Description
1 online resource (352 pages).
Additional Creators
Berhardt, Leon V.
Access Online

Availability

I Want It
I Want It

Finding items...

Series
Contents
ADVANCES IN MEDICINE AND BIOLOGY. VOLUME 38; ADVANCES IN MEDICINE AND BIOLOGY; ADVANCES IN MEDICINE AND BIOLOGY.; VOLUME 38; Library of Congress Cataloging-in-Publication Data; Contents; Preface; CHAPTER 1. Endogenous Angiogenesis Inhibitors: Is the List Ever Ending?; Abstract; 1. Introduction; 2. Secreted Angiogenesis Inhibitors; 2.1. Parstatin; 2.2. Semaphorin3A; 2.3. Isthmin; 2.4. Ý2-glycoprotein-I (Ý2GPI); 2.5. ADAMTS: A Family of Antiangiogenic Metalloproteinases; 2.5.1. ADAMTS1; 2.5.2. ADAMTS2; 2.5.3. ADAMTS4; 2.5.4. ADAMTS5; 2.5.5. ADAMTS8; 2.5.6. ADAMTS9; 2.5.7. ADAMTS12., 3. Cytoplasmic Angiogenesis Inhibitors3.1. Integrin Cytoplasmic Domain Associated Protein-1 (ICAP-1); 3.2. Epithelial Protein Lost In Neoplasm (EPLIN); 3.3. ASK1-Interacting Protein1 (AIP1); 3.4. microRNA; 3.4.1. miRNA-221/222; 3.4.2. miRNA-15 and miRNA-16; 3.4.3. miRNA-21; 3.4.4. miRNA-34a; 3.4.5. miRNA-519c and miRNA-107; 3.4.6. miRNA-179̃2 Cluster; Conclusion; Non-Standard Abbreviations and Acronyms; References; CXHAPTER 2. Angiogenesis, Lymphangiogenesis and Vasculogenic Mimicry in Human Prostate Cancer TherapyJingli; Abstract; Introduction; Prostate Cancer and Angiogenesis., Angiogenesis Activators as Therapeutic Targets for Prostate Cancer1. VEGF and VEGFR; 1.1. VEGF in Prostate Cancer Therapy; 1.2. VEGFR in Prostate Cancer Therapy; 2. Integrin ÜvÝ3 in Human Prostate Cancer; Angiostatin and Endostatin in Human Prostate Cancer Angiogenesis; Notch Singalling Pathway and Angiogenesis Paradox in Prostate Cancer; Lymphangiogenesis and Lymph Node Metastasis in Prostate Cancer; Vasculogenic Mimicry and Prostate Cancer; Conclusions and Future Directions; Acknowledgements; Abbreviations; References., CHAPTER 3. Structural and Functional Alteration of the Aging Lower Urinary TractAbbreviation; Abstract; Introduction; Epidemiology and Lower Urinary Tract Symptoms in the Elderly; Females; Males; Nocturia; Detrusor Underactivity; Quality of Life; Basic Research on the Structural and Functional Changes of the Aging Bladder; Bladder Contraction and Relaxation; Muscarinic Receptors Changes; Nerve Innervation of the Urinary Bladder; Non-Neuronal Ach Release; Change in Detrusor Contractility; Specific Considerations; Bladder Outlet Obstruction; Diabetes Mellitus; Detrusor Overactivity., and Detrusor UnderactivityClinical Research on Functional Changes of the Aging Bladder; General Voiding Parameters; Detrusor Overactivity; Detrusor Underactivity with or without Overactivity; Bladder Outlet Obstruction; Nocturia; Clinical Assessment of Elderly Patients with Lower Urinary Tract Dysfunction; Non-Urologic Causes; Drugs that Affect Voiding; Physical Examination and Laboratory Tests; Frequency-Volume Chart, and Post-Void Residual and Uroflowmetry; Urodynamic Evaluation; Management of the Aging Bladder; Life-Style Modification; Bladder Outlet Obstruction.
Subject(s)
ISBN
9781621002055 (electronic bk.)
1621002055 (electronic bk.)
Note
Title from PDF title page (viewed on March 26, 2013).
Bibliography Note
Includes bibliographical references and index.
View MARC record | catkey: 43236466